Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
15 December, 2018 00:21 IST
SBI announces special loan for repair and renovation of homes in Kerala
Source: IRIS | 04 Sep, 2018, 09.26AM
Comments  |  Post Comment

State Bank (Q,N,C,F)* of India (SBI) announced special term loan for repair and renovation of homes to help the flood affected citizens of Kerala. Under this scheme SBI offers loan of upto Rs 10 lakh at a reduced interest rate of 8.45% per annum along with waiver of processing fee.

The special rate will be applicable for home loan applications for repair and renovation submitted on or before November 30, 2018.

There has been unprecedented damage of property in the State of Kerala during flood and the need of the hour is to repair and renovate residences to bring numerous lives to normalcy. To meet this crucial requirement SBI has customize this loan offering for urgent requirement of funds by the people of Kerala at minimal charges.

Shares of the bank gained Rs 3.6, or 1.17%, to trade at Rs 310.00. The total volume of shares traded was 0 at the BSE (9.03 a.m., Tuesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Suzlon secures 50.4 MW order from Atria Power - 13-Dec-2018 13:11
Vikas Wsp wins orders worth Rs 2.06 bn - 13-Dec-2018 12:18
Strides Pharma receives USFDA approval for Lidocaine ointment - 13-Dec-2018 10:00
Tata Power eevamps customer portal - 13-Dec-2018 09:31
NBCC wins order worth Rs 1.72 bn from Govt of India - 13-Dec-2018 09:26
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharma gets USFDA approval for Ranitidine injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer